#24401
#24402
Re: Farmas USA
#24403
Re: Farmas USA
#24404
Re: Farmas USA
#24405
Re: Farmas USA
#24406
Re: Farmas USA
#24407
Re: Farmas USA
retroceso de casi el 50% de toda la subida desde el 28 diciembre.
BioLineRx Ltd. (Nasdaq: BLRX) 16.0% LOWER; announced that, as previously disclosed, results from the interim analysis of the Phase II/III CLARITY clinical trial of BL-1020...The Company hereby emphasizes that as the CLARITY trial is on-going and given the double-blind trial design, BioLineRx at present has no insight into the results of the interim analysis. Any media reports or comments by those outside of the Company regarding the outcome of the interim results of the CLARITY trial are merely based on speculation.
#24408
Re: Farmas USA
De ZLCS ya no se habla nadie...el niño prometedor de enolagay?